Health perspective: More kids are dying of misprescrribed attention deficit
drugs in one country, the U.S., than have died world wide in same time period
from AVIAN FLU hoax. AND--all possible is done to inflate the latter statistic
and minimize the former. These numbers don't account for teen suicide which
overwhelms all other relevant numbers--- Damaging children for the sake of
profits It also noted that children as young as five have committed
suicide while ... number of children labeled as having Attention Deficit
Disorders is man-made. ...
www.onlinejournal.com/health/082605Pringle/082605pringle.html Take care,
Francisco.
http://www.ablechild.org/newsarchive/FDA%20Reports%2051%20Deaths%20of%20ADHD%20Patients%202-9-06.htm
http://www.ablechild.org/newsarchive.htm Reuters FDA reports 51 deaths of
attention drug patients WASHINGTON - Deaths of 51 U.S. patients who took
widely prescribed drugs to treat attention deficit disorder prompted regulators
to start watching for heart attacks, high blood pressure and other problems in
2004, a report released on Wednesday said.
The U.S. Food and Drug Administration staff did not say the drugs were
responsible for the fatalities, but they urged close monitoring for "the rare
occurrence of pediatric sudden death during stimulant therapy."
"These reports themselves do not establish a causal relationship between
these medications and cardiovascular adverse events," wrote Dr. Gerald Dal Pan,
director of the FDA's Office of Drug Safety, in a separate notice on the agency
Web site.
The information was released one day ahead of an FDA advisory panel meeting
on how best to study potential risks from the drugs, which include Shire
Pharmaceuticals Group Plc's Adderall and Novartis AG's Ritalin.
FDA staff scientists and experts will provide updated information at the
meeting about serious health problems that have been reported, the agency said.
Use of drugs to treat attention deficit hyperactivity disorder, or ADHD, was
controversial before the cardiac issue emerged, with many doctors and parents
arguing the medicines are overprescribed.
The FDA said it decided to seek input from an advisory panel after reports of
sudden death, high blood pressure, heart attacks and strokes among some of the
millions of adults and children who have taken the medicines.
Through 2003, 24 deaths were reported from 1999 through 2003 among U.S.
patients who took Adderall for ADHD, the FDA staff report said. The agency
excluded cases that appeared linked to intoxication from multiple drugs or
other causes.
Another 16 deaths were reported through 2003 in U.S. patients who took
Ritalin or other ADHD drugs known as methylphenidates, the report said. Eleven
deaths were reported among other drugs besides Adderall in the amphetamine
class, it said.
"Conclusions about the relative safety of these two stimulant therapies
cannot be made on the basis of this analysis," the FDA staff said.
Thirty additional deaths of methylphenidate patients were recorded but they
were either non-U.S. cases or occurred outside the review period, the report
said.
Shire spokesman Matthew Cabrey said data have not shown any correlation
between Adderall and the sudden deaths reported among children. He said the
company supports the FDA's review of the matter.
Health Canada temporarily suspended Adderall sales last year after 20 reports
of sudden death in people who took it. The agency allowed Adderall back on the
market after concluding it could not prove the drug was more risky than other
therapies.
Novartis said its own review found no increased risk of cardiovascular
problems in patients who took methylphenidates compared with the general
population.
The FDA also has been studying if ADHD drugs may be related to psychiatric
problems.
Republican Sen. Charles Grassley charged the FDA had taken a "disjointed"
approach to the drugs over the past year. In a letter to the agency, the Iowa
Republican suggested a "comprehensive" review of all ADHD medicines.
Shares of British firm Shire fell 3.2 percent to 890.2 pence in London
trading. Novartis shares gained 5 cents to close at $54.70 on the New York
Stock Exchange
---------------------------------
Want to be your own boss? Learn how on Yahoo! Small Business.
[Non-text portions of this message have been removed]
ForumWebSiteAt http://groups.yahoo.com/group/Libertarian
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/Libertarian/
<*> To unsubscribe from this group, send an email to:
[EMAIL PROTECTED]
<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/
